According to recent press reports, five UK biotech firms have been holding secret talks on the possibility of a merger that would create a cancer research company fit to compete with the biggest drug and therapy giants in the world.
Both the
But the reports have been dismissed as "wishful thinking" by some of the companies involved, who insist there are no formal talks. Interestingly, nobody is attempting to deny that such consolidation would probably be in the best interests...